Respiratory Diseases
Breath biomarker discovery with Breath Biopsy® could lead to non-invasive precision medicine and exacerbation detection for asthma, COPD and other chronic airway diseases.
Learn More
Podcast: American Thoracic Society
Our CEO, Billy Boyle, talks to Andrew Bishop about Breath Biopsy for respiratory diseases on the ATS podcast.
Listen Now
Presentation: Anke-Hilse Matland-Van der Zee at BBCon22
Use of longitudinal breath measurements at home in chronic respiratory patients, future or fiction?
Watch Now
Webinar: Breath Biopsy for Respiratory Diseases
A research presentation that demonstrates the potential of Breath Biopsy for Respiratory Diseases.
View Webinar On-demand
Presentation: Chris Brightling at BBCon22
Breathomics for acute and chronic lung disease - getting closer to the clinic?
Go To Blog
Publication: Biomarkers of asthma phenotypes
Researchers at Liege University identified four VOCs to stratify key asthma phenotypes.
Read Publication
Partners
Our Partners
 |
 |
 |
 |
Further Reading
Other recommended reading:
- PUBLICATION: Breath Biopsy is well accepted by patients – EMBER researchers assess the acceptability of sample collection with ReCIVA for patients with acute breathlessness.
- POSTER: Biomarkers of stress in lungs – A study of ultramarathon runners used Breath Biopsy to uncover markers of physical lung stress and injury caused by extreme exercise.
- REVIEW: ReCIVA is an optimal sampling solution – A systematic review by Azim et al. identifies ReCIVA as an optimal solution for clinical utility in breath collection.
- PUBLICATION: VOCs, lung microbiome and COPD – Results from an early Breath Biopsy study with GSK examining VOCs on breath for insights into the lung microbiome in COPD patients.
- POSTER: Biomarkers of lung cancer in former smokers – A Breath Biopsy study with BC Cancer.
- POSTER: Biomarkers for IPF/ILA – Results of a Breath Biopsy study at Brigham and Women’s Hospital.
- PAPER: Applications of VOC Biomarkers in Asthma – Our whitepaper on the use of breath biomarkers for asthma diagnosis and treatment.
- REPORT: Breath biomarkers an asthma priority – An expert European partnership identifies VOC biomarkers on breath as a key asthma research priority.
- ARTICLE: The Pathologist looks at breath biomarkers – An article summarising the use of breath for early detection and precision medicine.
- PAPER: Volatile organic breath components and exercise induced bronchoconstriction in asthmatic children
- PAPER: Exhaled volatile organic compounds and lung microbiome in COPD
- PAPER: Millimeter-wave gas spectroscopy for breathanalysis of COPD patients in comparison to GC-MS
